Perrigo Company plc (NYSE: PRGO)
Health Care · Pharmaceuticals · IE
$15.41
+2.32% today · -30.1% 1Y
Perrigo Company plc (NYSE: PRGO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.09B and employs 8,100 people.
Over the last twelve months the share price has lost 30.1%, trading between 9.23 and 22.21.
Tweenvest scores Perrigo Company plc across four factors: quality 59/100, value 75/100, growth 8/100, dividend 84/100. Its strongest factor is dividend.
PRGO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.09B
- Revenue (TTM)
- $4.14B
- P/E
- —
- EPS
- -12.49
- Dividend yield
- 8.00%
- Beta (5Y)
- 0.69
- 52-week high
- $22.21
- 52-week low
- $9.23
- Avg volume (3M)
- —
- Shares outstanding
- 138.77M
- Employees
- 8,100
- Next earnings
- —
About Perrigo Company plc
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
- ISIN
- IE00BGH1M568
- Founded
- 1887
- Listed since
- Dec 17, 1991
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| China Resources Jiangzhong Pharmaceutical Co.,LtdSHSE: 600750 | $2.15B | CN¥22.88 | +1.24% |
| Dermapharm Holding SEXTRA: DMP | $2.13B | €38.30 | -0.26% |
| Grand Pharmaceutical Group LimitedSEHK: 512 | $2.12B | HK$4.74 | -1.76% |
| Zhejiang Jiuzhou Pharmaceutical Co., LtdSHSE: 603456 | $2.09B | CN¥16.31 | -2.63% |
| Granules India LimitedBSE: 532482 | $2.08B | Rs813.85 | -0.85% |
| Zhejiang Hisun Pharmaceutical Co., Ltd.SHSE: 600267 | $2.06B | CN¥11.94 | +1.62% |
| Shilpa Medicare LimitedBSE: 530549 | $2.06B | Rs1,020.35 | -4.07% |
| Trulieve Cannabis Corp.NYSE: TRLV | $2.05B | $10.67 | +2.89% |
Figures last refreshed Oct 11, 2026.